EUVIMEDEUVIMED entdecken
Open Access

SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity

Aulia Fitri Rhamadianti, Takayuki Abe, Tomohisa Tanaka, Chikako Ono, Hisashi Katayama, Yoshiteru Makino, Lin Deng, Chieko Matsui, Kohji Moriishi iD, Fumi Shima, Yoshiharu Matsuura iD, Ikuo Shoji iD

Journal of Virology · 17.09.2024 · 98 (9)

DOI: 10.1128/jvi.00855-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 17.09.2024. Verfasst von Aulia Fitri Rhamadianti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease Control, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Ubiquitins, SARS-CoV-2, Cytokines, Coronavirus Nucleocapsid Proteins. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kansai Economic Federation (KEF), Hyogo Science and Technology Association (HSTA), Ministry of Education, Culture, Sports, Science and Technology (MEXT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes mild-to-severe respiratory symptoms, including acute respiratory distress. Despite remarkable efforts to investigate the virological and pathological impacts of SARS-CoV-2, many of the characteristics of SARS-CoV-2 infection still remain unknown. The interferon-inducible ubiquitin-like protein ISG15 is covalently conjugated to several viral proteins to suppress their functions. It was reported that SARS-CoV-2 utilizes its papain-like protease (PLpro) to impede ISG15 conjugation, ISGylation. However, the role of ISGylation in SARS-CoV-2 infection remains unclear. We aimed to elucidate the role of ISGylation in SARS-CoV-2 replication. We observed that the SARS-CoV-2 nucleocapsid protein is a target protein for the HERC5 E3 ligase-mediated ISGylation in cultured cells. Site-directed mutagenesis reveals that the residue K374 within the C-terminal spacer B-N3 (SB/N3) domain is required for nucleocapsid-ISGylation, alongside conserved lysine residue in MERS-CoV (K372) and SARS-CoV (K375). We also observed that the nucleocapsid-ISGylation results in the disruption of nucleocapsid oligomerization, thereby inhibiting viral replication. Knockdown of ISG15 mRNA enhanced SARS-CoV-2 replication in the SARS-CoV-2 reporter replicon cells, while exogenous expression of ISGylation components partially hampered SARS-CoV-2 replication. Taken together, these results suggest that SARS-CoV-2 PLpro inhibits ISGylation of the nucleocapsid protein to promote viral replication by evading ISGylation-mediated disruption of the nucleocapsid oligomerization. IMPORTANCE ISG15 is an interferon-inducible ubiquitin-like protein that is covalently conjugated to the viral protein via specific Lys residues and suppresses viral functions and viral propagation in many viruses. However, the role of ISGylation in SARS-CoV-2 infection remains largely unclear. Here, we demonstrated that the SARS-CoV-2 nucleocapsid protein is a target protein for the HERC5 E3 ligase-mediated ISGylation. We also found that the residue K374 within the C-terminal spacer B-N3 (SB/N3) domain is required for nucleocapsid-ISGylation. We obtained evidence suggesting that nucleocapsid-ISGylation results in the disruption of nucleocapsid-oligomerization, thereby suppressing SARS-CoV-2 replication. We discovered that SARS-CoV-2 papain-like protease inhibits ISG15 conjugation of nucleocapsid protein via its de-conjugating enzyme activity. The present study may contribute to gaining new insight into the roles of ISGylation-mediated anti-viral function in SARS-CoV-2 infection and may lead to the development of more potent and selective inhibitors targeted to SARS-CoV-2 nucleocapsid protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquitinsSARS-CoV-2CytokinesCoronavirus Nucleocapsid ProteinsCOVID-19Virus ReplicationUbiquitin-Protein LigasesCoronavirus Papain-Like ProteasesHumansHEK293 CellsPhosphoproteinsImmune EvasionNucleocapsid ProteinsCoronavirus 3C ProteasesIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

ISG15SARS-CoV-2anti-viral activitynucleocapsidpapain-like protease

Substanzen

UbiquitinsISG15 protein, humanCytokinesCoronavirus Nucleocapsid Proteinsnucleocapsid phosphoprotein, SARS-CoV-2HERC5 protein, humanUbiquitin-Protein Ligasespapain-like protease, SARS-CoV-2Coronavirus Papain-Like ProteasesPhosphoproteins

Autor:innen und Institutionen

  • Division of Infectious Disease Control, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  • Department of Virology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi, Japan.
  • Division of Hepatitis Virology, Institute for Genetic Medicine, Hokkaido University, Hokkaido, Japan.
  • Center for Infectious Diseases Education and Research (CiDER), Osaka University, Osaka, Japan.

ORCID-Profile: Kohji Moriishi, Yoshiharu Matsuura, Ikuo Shoji

Förderung

  • Kansai Economic Federation (KEF)
  • Hyogo Science and Technology Association (HSTA)
  • Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Zitieren

APA

Rhamadianti, A. F., Abe, T., Tanaka, T., Ono, C., Katayama, H., Makino, Y., Deng, L., Matsui, C., Moriishi, K., Shima, F., Matsuura, Y., & Shoji, I. (2024). SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity. Journal of Virology, 98(9). https://doi.org/10.1128/jvi.00855-24

Vancouver

Rhamadianti AF, Abe T, Tanaka T, Ono C, Katayama H, Makino Y, et al. SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity. Journal of Virology. 2024;98(9). doi:10.1128/jvi.00855-24

BibTeX
@article{Rhamadianti2024,
  author = {Rhamadianti, Aulia Fitri and Abe, Takayuki and Tanaka, Tomohisa and Ono, Chikako and Katayama, Hisashi and Makino, Yoshiteru and Deng, Lin and Matsui, Chieko and Moriishi, Kohji and Shima, Fumi and Matsuura, Yoshiharu and Shoji, Ikuo},
  title = {SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {9},
  doi = {10.1128/jvi.00855-24}
}
Kostenlos starten →